港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

派格生物医药-B

60.700

-2.550-4.03%

成交量：83.41万

成交额：5,333.91万

市值：234.30亿

市盈率：-71.86

高：72.750

开：72.700

低：55.050

收：63.250

52周最高：72.750

52周最低：8.680

股本：3.86亿

香港流通股本：2.79亿

量比：3.98

换手率：0.30%

股息：- -

股息率：- -

每股收益(LYR):-0.845

净资产收益率：-224.15%

总资产收益率：-61.30%

市净率：83.93

市盈率(LYR):-71.86

市销率: -5527.88

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

港股异动 | 派格生物医药-B(02565)高开近15% 核心产品PB-119新药上市申请获批

派格生物长效 GLP-1“维培那肽”获批上市

一周港股牛熊榜 | 减肥药赛道升温，歌礼一周飙45%；进入“万店俱乐部”，沪上阿姨涨31%；月活跃用户减少，腾讯音乐跌14%

老虎资讯综合

派格生物医药-B(02565)：中国国家药监局批准PB-119新药上市申请

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02565"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02565","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","market":"HK","secType":"STK","nameCN":"派格生物医药-B","latestPrice":60.7,"timestamp":1763366400014,"preClose":63.25,"halted":0,"volume":834050,"delay":0,"floatShares":279164339,"shares":386000000,"eps":-0.8446884252726156,"marketStatus":"收市竞价","change":-2.55,"latestTime":"11-17 16:01:13","open":72.7,"high":72.75,"low":55.05,"amount":53339050,"amplitude":0.279842,"askPrice":60.7,"askSize":9500,"bidPrice":60.7,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.6571627973667235,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1763367000000},"marketStatusCode":4,"adr":0,"listingDate":1748275200000,"exchange":"SEHK","adjPreClose":63.25,"openAndCloseTimeList":[[1763343000000,1763352000000],[1763355600000,1763366400000]],"volumeRatio":3.979246,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","floatShares":279164339,"roa":"-61.30%","roe":"-224.15%","lyrEps":-0.844688,"volumeRatio":3.979246,"shares":386000000,"dividePrice":0,"high":72.75,"amplitude":0.279842,"preClose":63.25,"low":55.05,"week52Low":8.68,"pbRate":"83.93","psRate":"-5527.88","week52High":72.75,"institutionHeld":0,"latestPrice":60.7,"committee":-0.9,"eps":-0.8446884252726156,"divideRate":0,"volume":834050,"delay":0,"ttmEps":-0.6571627973667235,"open":72.7,"prevYearClose":15.6,"prevWeekClose":63.25,"prevMonthClose":60.1,"prevQuarterClose":54.2,"fiveDayClose":53.4,"twentyDayClose":52.05,"sixtyDayClose":30.76},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02565\",params:#limit:5,,,undefined,":[{"date":"2025-08-26","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02565\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02565\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":0,"sell":0,"strongSell":1,"meanLabel":"STRONG SELL","meanPercent":1,"analysts":1,"updateTime":1755187200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02565\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02565","date":"2025-11-14","current":-96.473383,"percent":0,"low":-72.819022,"twenty":-61.035505,"median":-39.959751,"eighty":-12.906561,"high":-11.114373,"avg":-37.222505,"sd":22.07937,"marketCap":17657144441},"quantilePoints":[{"date":"2025-05-30","current":-12.743079,"twenty":-15.470266,"median":-13.542645,"eighty":-13.135794,"marketCap":3936746426},{"date":"2025-06-06","current":-11.987888,"twenty":-13.726785,"median":-12.740515,"eighty":-12.114178,"marketCap":3712892217},{"date":"2025-06-13","current":-11.23576,"twenty":-13.295707,"median":-12.114337,"eighty":-11.528404,"marketCap":3481318898},{"date":"2025-06-20","current":-11.30775,"twenty":-12.841258,"median":-11.963331,"eighty":-11.337793,"marketCap":3496757119},{"date":"2025-06-27","current":-12.421214,"twenty":-12.738977,"median":-11.541778,"eighty":-11.292079,"marketCap":3851836209},{"date":"2025-07-04","current":-13.963875,"twenty":-12.971799,"median":-11.987888,"eighty":-11.299391,"marketCap":4330421069},{"date":"2025-07-11","current":-13.604213,"twenty":-13.050401,"median":-12.199189,"eighty":-11.305737,"marketCap":4214634409},{"date":"2025-07-18","current":-16.956264,"twenty":-13.748078,"median":-12.438987,"eighty":-11.330282,"marketCap":5248995235},{"date":"2025-07-25","current":-19.006677,"twenty":-15.472199,"median":-12.742066,"eighty":-11.352726,"marketCap":5905119639},{"date":"2025-08-01","current":-19.199848,"twenty":-18.276271,"median":-12.906561,"eighty":-11.424474,"marketCap":5928276971},{"date":"2025-08-08","current":-20.51103,"twenty":-19.019895,"median":-13.05938,"eighty":-11.472546,"marketCap":6348968501},{"date":"2025-08-15","current":-39.959751,"twenty":-19.179784,"median":-13.542645,"eighty":-11.515029,"marketCap":12350577024},{"date":"2025-08-22","current":-41.864246,"twenty":-19.284777,"median":-13.964282,"eighty":-11.779976,"marketCap":12898633879},{"date":"2025-08-29","current":-41.44792,"twenty":-21.432837,"median":-14.946806,"eighty":-11.968242,"marketCap":10033166343},{"date":"2025-09-05","current":-50.678037,"twenty":-39.039264,"median":-17.018603,"eighty":-12.06328,"marketCap":12255314482},{"date":"2025-09-12","current":-58.538001,"twenty":-40.749762,"median":-18.438762,"eighty":-12.114019,"marketCap":14181548421},{"date":"2025-09-19","current":-57.311117,"twenty":-43.720929,"median":-18.952908,"eighty":-12.216159,"marketCap":13874467648},{"date":"2025-09-26","current":-63.587749,"twenty":-49.33228,"median":-19.070122,"eighty":-12.366345,"marketCap":15354038645},{"date":"2025-10-03","current":-60.149194,"twenty":-54.575673,"median":-19.16943,"eighty":-12.428323,"marketCap":14558420278},{"date":"2025-10-10","current":-60.121463,"twenty":-57.957283,"median":-19.199848,"eighty":-12.49878,"marketCap":14530503844},{"date":"2025-10-17","current":-60.168303,"twenty":-59.756564,"median":-19.2984,"eighty":-12.738571,"marketCap":14530503844},{"date":"2025-10-24","current":-61.301982,"twenty":-60.143648,"median":-20.51103,"eighty":-12.741458,"marketCap":14809668183},{"date":"2025-10-31","current":-69.345185,"twenty":-60.159469,"median":-22.018639,"eighty":-12.743079,"marketCap":16777776773},{"date":"2025-11-07","current":-59.401661,"twenty":-60.392128,"median":-34.33922,"eighty":-12.780248,"marketCap":14363005241},{"date":"2025-11-14","current":-72.819022,"twenty":-61.035505,"median":-39.959751,"eighty":-12.906561,"marketCap":17657144441}],"updateTime":1763353808626},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02565\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584697958","title":"港股异动 | 派格生物医药-B(02565)高开近15% 核心产品PB-119新药上市申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2584697958","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584697958?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 09:28","pubTimestamp":1763342919,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，派格生物医药-B高开近15%，截至发稿，涨14.94%，报72.7港元，成交额112.69万港元。消息面上，11月14日，派格生物医药-B发布公告，中国国家药品监督管理局已批准本公司核心产品PB-119的新药上市申请。该产品为国家科技重大专项认定为“重大新药创制”的国家原创1类新药。PB-119可显著改善β细胞功能，除血糖外，兼具全面管理患者的血压、血脂及体重，实现“四高共管，全面获益”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BLDYK493.USD","399441","BK1161","161726","BK4211","02565","PB","IE00B64QTZ34.USD"],"gpt_icon":0},{"id":"2583663186","title":"派格生物长效 GLP-1“维培那肽”获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2583663186","media":"药事纵横","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583663186?lang=zh_cn&edition=fundamental","pubTime":"2025-11-16 08:03","pubTimestamp":1763251394,"startTime":"0","endTime":"0","summary":"NMPA发布2025年11月14日药品批准证明文件送达信息，本批次共有129个受理号获批，其中：派格生物的维培那肽注射液获批上市，用于改善成人2型糖尿病患者的血糖控制。此外，维培那肽在降压、调脂等改善心血管危险因素方面均具有显著作用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116084057a6fc31e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116084057a6fc31e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565","BK1161"],"gpt_icon":0},{"id":"1157409611","title":"一周港股牛熊榜 | 减肥药赛道升温，歌礼一周飙45%；进入“万店俱乐部”，沪上阿姨涨31%；月活跃用户减少，腾讯音乐跌14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157409611","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157409611?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 18:01","pubTimestamp":1763114515,"startTime":"0","endTime":"0","summary":"2589.HK本周上涨约 +31.4%，“沪上阿姨”成功进入“万店俱乐部”根据极海品牌监测数据显示，截至目前，“沪上阿姨”品牌全国门店数量已达10739家，成功进入“万店俱乐部”。该产品为国家科技重大专项认定为“重大新药创制”的国家原创1类新药。1698.HK本周下跌约 –14.28%，第三季non-IFRS净利润按年升逾32%惟月活跃用户减少消息面上，腾讯音乐第三季总收入84.63亿人民币(下同)，按年增长20.6%。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01910","02473","02565","01698","01333","02570","00179","02026","01672","02589"],"gpt_icon":1},{"id":"2583575859","title":"派格生物医药-B(02565)：中国国家药监局批准PB-119新药上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2583575859","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583575859?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 16:35","pubTimestamp":1763109331,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B 发布公告，中国国家药品监督管理局已批准本公司核心产品PB-119的新药上市申请。派达康为本公司开发的新一代长效胰高血糖素样肽-1受体激动剂，每周给药一次。该产品为国家科技重大专项认定为“重大新药创制”的国家原创1类新药。这一结构性修改使药物与GLP-1受体高效结合并发挥生物学效应。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369303.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","IE00B64QTZ34.USD","BK4211","PB","161726","02565","IE00BLDYK493.USD","399441"],"gpt_icon":0}],"pageSize":4,"totalPage":21,"pageCount":1,"totalSize":82,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02565\",params:#limit:6,delay:false,,,undefined,":[]}}